{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T23:04:56Z","timestamp":1761433496351,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.soc.2025.04.002","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T15:42:45Z","timestamp":1747410165000},"page":"637-652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Defining Resectability in Locally-Advanced Disease"],"prefix":"10.1016","volume":"34","author":[{"given":"Miriam","family":"Patella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora Maddalena","family":"Minerva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"Battilana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Steinmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Opitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.soc.2025.04.002_bib1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jamaoncol.2023.5276","article-title":"Rapid advances in resectable non-small cell lung cancer: a narrative review","volume":"10","author":"West","year":"2024","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.soc.2025.04.002_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer","volume":"11","author":"Goldstraw","year":"2016","journal-title":"J Thorac Oncol"},{"issue":"2","key":"10.1016\/j.soc.2025.04.002_bib3","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/jso.27183","article-title":"The oncologic efficacy of extended resections for lung cancer","volume":"127","author":"Etienne","year":"2023","journal-title":"J Surg Oncol"},{"issue":"4","key":"10.1016\/j.soc.2025.04.002_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11864-019-0624-7","article-title":"The role of surgery in management of locally advanced non-small cell lung cancer","volume":"20","author":"Bryan","year":"2019","journal-title":"Curr Treat Options Oncol"},{"issue":"3 Suppl","key":"10.1016\/j.soc.2025.04.002_bib5","doi-asserted-by":"crossref","first-page":"243S","DOI":"10.1378\/chest.07-1379","article-title":"Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition)","volume":"132","author":"Robinson","year":"2007","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.soc.2025.04.002_bib6","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jtho.2023.10.012","article-title":"The international association for the study of lung cancer staging project for lung cancer: proposals for the revision of the N descriptors in the forthcoming ninth edition of the TNM classification for lung cancer","volume":"19","author":"Huang","year":"2024","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1016\/j.soc.2025.04.002_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.lungcan.2005.01.001","article-title":"Complete resection in lung cancer surgery: proposed definition","volume":"49","author":"Rami-Porta","year":"2005","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.soc.2025.04.002_bib8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jtho.2019.10.019","article-title":"The IASLC lung cancer staging project: analysis of resection margin status and proposals for residual tumor descriptors for non-small cell lung cancer","volume":"15","author":"Edwards","year":"2020","journal-title":"J Thorac Oncol"},{"issue":"5","key":"10.1016\/j.soc.2025.04.002_bib9","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.ejcts.2006.08.008","article-title":"ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer","volume":"30","author":"Lardinois","year":"2006","journal-title":"Eur J Cardio Thorac Surg"},{"issue":"5","key":"10.1016\/j.soc.2025.04.002_bib10","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/ejcts\/ezu016","article-title":"European guidelines on structure and qualification of general thoracic surgery","volume":"45","author":"Brunelli","year":"2014","journal-title":"Eur J Cardio Thorac Surg"},{"issue":"10","key":"10.1016\/j.soc.2025.04.002_bib11","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jtho.2024.06.010","article-title":"Neoadjuvant and adjuvant treatments for early stage resectable NSCLC: consensus recommendations from the International Association for the study of Lung Cancer","volume":"19","author":"Spicer","year":"2024","journal-title":"J Thorac Oncol"},{"issue":"6","key":"10.1016\/j.soc.2025.04.002_bib13","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jtcvs.2022.03.034","article-title":"Extended resection for potentially operable patients with stage III non-small cell lung cancer after induction treatment","volume":"164","author":"Furrer","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.soc.2025.04.002_bib14","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.athoracsur.2020.05.084","article-title":"Neoadjuvant treatment is associated with superior outcomes in T4 lung cancers with local extension","volume":"111","author":"Towe","year":"2021","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"10.1016\/j.soc.2025.04.002_bib15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/jama.2023.24735","article-title":"Perioperative toripalimab plus chemotherapy for patients with resectable non-small cell lung cancer: the neotorch randomized clinical trial","volume":"331","author":"Lu","year":"2024","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.soc.2025.04.002_bib16","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","article-title":"Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer","volume":"386","author":"Forde","year":"2022","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.soc.2025.04.002_bib17","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1056\/NEJMoa2311926","article-title":"Perioperative nivolumab in resectable lung cancer","volume":"390","author":"Cascone","year":"2024","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.soc.2025.04.002_bib18","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1056\/NEJMoa2304875","article-title":"Perioperative durvalumab for resectable non-small-cell lung cancer","volume":"389","author":"Heymach","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.soc.2025.04.002_bib19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa2302983","article-title":"Perioperative pembrolizumab for early-stage non-small-cell lung cancer","volume":"389","author":"Wakelee","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.soc.2025.04.002_bib20","article-title":"Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial","author":"Yue","year":"2024","journal-title":"Lancet Respir Med"},{"issue":"10","key":"10.1016\/j.soc.2025.04.002_bib21","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.annonc.2023.07.001","article-title":"Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial","volume":"34","author":"Felip","year":"2023","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.soc.2025.04.002_bib22","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S1470-2045(22)00518-6","article-title":"Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS\/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial","volume":"23","author":"O\u2019Brien","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.soc.2025.04.002_bib23","doi-asserted-by":"crossref","first-page":"ii30","DOI":"10.1093\/annonc\/mdz064.014","article-title":"IMpower030: phase III study evaluating neoadjuvant treatment of resectable stage II-IIIB non-small cell lung cancer (NSCLC) with atezolizumab (atezo) + chemotherapy","volume":"30","author":"Peters","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.soc.2025.04.002_bib24","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.2147\/CMAR.S453924","article-title":"Safety and efficacy of neoadjuvant chemoimmunotherapy versus chemotherapy for non-small cell lung cancer undergoing sleeve resection","volume":"16","author":"Qiu","year":"2024","journal-title":"Cancer Manag Res"},{"issue":"12","key":"10.1016\/j.soc.2025.04.002_bib25","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.annonc.2021.08.1994","article-title":"Electronic address: clinicalguidelines@esmo.org. Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapy","volume":"32","author":"Remon","year":"2021","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.soc.2025.04.002_bib26","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/ejcts\/ezu028","article-title":"Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer","volume":"45","author":"De Leyn","year":"2014","journal-title":"Eur J Cardio Thorac Surg"},{"issue":"Suppl 1","key":"10.1016\/j.soc.2025.04.002_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41416-020-01069-z","article-title":"The current treatment landscape in the UK for stage III NSCLC","volume":"123","author":"Evison","year":"2020","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.soc.2025.04.002_bib28","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1200\/JCO.2003.11.040","article-title":"Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial","volume":"21","author":"Betticher","year":"2003","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.soc.2025.04.002_bib29","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1470-2045(09)70172-X","article-title":"Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol"},{"issue":"9998","key":"10.1016\/j.soc.2025.04.002_bib30","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(15)60294-X","article-title":"Induction chemoradiation in stage IIIA\/N2 non-small-cell lung cancer: a phase 3 randomised trial","volume":"386","author":"Pless","year":"2015","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.soc.2025.04.002_bib31","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1056\/NEJMoa2215530","article-title":"Perioperative nivolumab and chemotherapy in stage III non-small-cell lung cancer","volume":"389","author":"Provencio","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.soc.2025.04.002_bib32","article-title":"An international and multidisciplinary EORTC survey on resectability of stage III non-small cell lung cancer","author":"Houda","year":"2024","journal-title":"Lung Cancer"},{"key":"10.1016\/j.soc.2025.04.002_bib33","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.jtho.2023.09.046","article-title":"OA06.05 consensual definition of stage III NSCLC resectability: EORTC-lung cancer group initiative with other scientific societies","volume":"18","author":"Dingemans","year":"2023","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.soc.2025.04.002_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102833","article-title":"Surgical and safety outcomes in patients with non-small cell lung cancer receiving neoadjuvant chemoimmunotherapy versus chemotherapy alone: a systematic review and meta-analysis","volume":"131","author":"Aburaki","year":"2024","journal-title":"Cancer Treat Rev"},{"issue":"20","key":"10.1016\/j.soc.2025.04.002_bib35","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.soc.2025.04.002_bib36","article-title":"Surgery for patients with cT3\/4N2M0, stage IIIB NSCLC. Is it time to redefine resectability?","volume":"6","author":"Rodriguez-Quintero","year":"2024","journal-title":"JTO Clin Res Rep"},{"issue":"5","key":"10.1016\/j.soc.2025.04.002_bib37","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.jtcvs.2022.01.019","article-title":"Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non-small cell lung cancer","volume":"164","author":"Sepesi","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.soc.2025.04.002_bib38","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jtcvs.2022.10.007","volume":"165","author":"Rusch","year":"2023","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"10","key":"10.1016\/j.soc.2025.04.002_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2024.09.434","article-title":"P2.07C.04 surgical complexity of anatomical lung resections after induction immunotherapy for locally advanced or metastatic non-small cell lung cancer","volume":"19","author":"Werner","year":"2024","journal-title":"J Thorac Oncol"},{"issue":"171","key":"10.1016\/j.soc.2025.04.002_bib40","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0195-2023","article-title":"Resectable non-stage IV nonsmall cell lung cancer: the surgical perspective","volume":"33","author":"Aigner","year":"2024","journal-title":"Eur Respir Rev"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320725000365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320725000365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T23:01:08Z","timestamp":1761433268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320725000365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1055320725000365"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2025.04.002","relation":{},"ISSN":["1055-3207"],"issn-type":[{"type":"print","value":"1055-3207"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining Resectability in Locally-Advanced Disease","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2025.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}